Volatile Organic Compounds Produced by a Deep-Sea Bacterium Efficiently Inhibit the Growth of Pseudomonas aeruginosa PAO1.
Yuanyuan HuGe LiuChaomin SunShimei WuPublished in: Marine drugs (2024)
The deep-sea bacterium Spongiibacter nanhainus CSC3.9 has significant inhibitory effects on agricultural pathogenic fungi and human pathogenic bacteria, especially Pseudomonas aeruginosa , the notorious multidrug-resistant pathogen affecting human public health. We demonstrate that the corresponding antibacterial agents against P. aeruginosa PAO1 are volatile organic compounds (VOCs, namely VOC-3.9). Our findings show that VOC-3.9 leads to the abnormal cell division of P. aeruginosa PAO1 by disordering the expression of several essential division proteins associated with septal peptidoglycan synthesis. VOC-3.9 hinders the biofilm formation process and promotes the biofilm dispersion process of P. aeruginosa PAO1 by affecting its quorum sensing systems. VOC-3.9 also weakens the iron uptake capability of P. aeruginosa PAO1, leading to reduced enzymatic activity associated with key metabolic processes, such as reactive oxygen species (ROS) scavenging. Overall, our study paves the way to developing antimicrobial compounds against drug-resistant bacteria by using volatile organic compounds.
Keyphrases
- pseudomonas aeruginosa
- biofilm formation
- acinetobacter baumannii
- drug resistant
- multidrug resistant
- staphylococcus aureus
- cystic fibrosis
- reactive oxygen species
- public health
- candida albicans
- endothelial cells
- induced pluripotent stem cells
- gram negative
- escherichia coli
- poor prognosis
- risk assessment
- stem cells
- single cell
- dna damage
- cell death
- heavy metals
- hydrogen peroxide
- binding protein
- silver nanoparticles
- anti inflammatory
- oxidative stress
- bacillus subtilis
- cell therapy
- left ventricular